We and other groups reported that NHERF1 could form signaling complexes with PTEN or tyrosine kinase receptors including PDGFR and EGFR to counterbalance AKT and ERK signaling in breast cancer cells [7,11]. Here, PTEN is linked to breast carcinoma.